# Kunle Odunsi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kunle-odunsi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,718 |
| Field | Immunotherapy and Immune Responses |
| h-index | 85 |
| i10-index | 338 |
| Last Known Institution | Roswell Park Comprehensive Cancer Center |
| OpenAlex ID | https://openalex.org/A5009400324 |
| ORCID iD | https://orcid.org/0000-0002-4444-7651 |
| Works | 995 |

## Researcher papers

- [Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer](https://scholariq.org/papers/safety-and-activity-of-anti-pd-l1-antibody-in-patients-with-advanced-cancer/)
- [Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk](https://scholariq.org/papers/common-genetic-variation-in-cellular-transport-genes-and-epithelial-ovarian/)
- [Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer](https://scholariq.org/papers/multiple-independent-variants-at-the-tert-locus-are-associated-with-telomere/)
- [Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer](https://scholariq.org/papers/association-of-type-and-location-of-i-brca1-i-and-i-brca2-i-mutations-with-risk/)
- [Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer](https://scholariq.org/papers/germline-mutations-in-the-brip1-bard1-palb2-and-nbn-genes-in-women-with-ovarian/)
- [Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study](https://scholariq.org/papers/hormone-receptor-expression-and-ovarian-cancer-survival-an-ovarian-tumor-tissue/)
- [Contribution of Germline Mutations in the <i>RAD51B</i>, <i>RAD51C</i>, and <i>RAD51D</i> Genes to Ovarian Cancer in the Population](https://scholariq.org/papers/contribution-of-germline-mutations-in-the-i-rad51b-i-i-rad51c-i-and-i-rad51d-i/)
- [Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells](https://scholariq.org/papers/suppressive-il-17a-foxp3-and-ex-th17-il-17anegfoxp3-treg-cells-are-a-source-of/)
- [Defining the critical hurdles in cancer immunotherapy](https://scholariq.org/papers/defining-the-critical-hurdles-in-cancer-immunotherapy/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Roswell Park Comprehensive Cancer Center](https://scholariq.org/institutions/roswell-park-comprehensive-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.